These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21303355)

  • 21. Microparticles in thrombosis and hemostasis.
    Key NS; Kwaan HC
    Semin Thromb Hemost; 2010 Nov; 36(8):805-6. PubMed ID: 21049380
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating microparticles, lupus anticoagulant and recurrent miscarriages.
    Alijotas-Reig J; Palacio-Garcia C; Vilardell-Tarres M
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):22-6. PubMed ID: 19410360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular mechanisms underlying the formation of circulating microparticles.
    Morel O; Jesel L; Freyssinet JM; Toti F
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):15-26. PubMed ID: 21160064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating microparticles and procoagulant activity in elderly patients.
    Forest A; Pautas E; Ray P; Bonnet D; Verny M; Amabile N; Boulanger C; Riou B; Tedgui A; Mallat Z; Boddaert J
    J Gerontol A Biol Sci Med Sci; 2010 Apr; 65(4):414-20. PubMed ID: 19942591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High concentrations of procoagulant microparticles in the cerebrospinal fluid and peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome.
    Huang M; Hu YY; Dong XQ
    Surg Neurol; 2009 Nov; 72(5):481-9; discussion 489. PubMed ID: 19328537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microparticles in physiological and in pathological conditions.
    Roos MA; Gennero L; Denysenko T; Reguzzi S; Cavallo G; Pescarmona GP; Ponzetto A
    Cell Biochem Funct; 2010 Oct; 28(7):539-48. PubMed ID: 20941744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane microvesicles: macromessengers in cancer disease and progression.
    Castellana D; Toti F; Freyssinet JM
    Thromb Res; 2010 Apr; 125 Suppl 2():S84-8. PubMed ID: 20434014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of circulating microparticles in liver transplant patients.
    Brodsky SV; Facciuto ME; Heydt D; Chen J; Islam HK; Kajstura M; Ramaswamy G; Aguero-Rosenfeld M
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):261-8. PubMed ID: 18836617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cell-derived microparticles unveil their fibrinolytic and proteolytic function].
    Doeuvre L; Angles-Cano E
    Med Sci (Paris); 2009 Jan; 25(1):37-44. PubMed ID: 19154692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy.
    Trappenburg MC; van Schilfgaarde M; Bredewold EO; van Aalderen MC; Spronk HM; Ten Cate H; Leyte A; Terpstra WE
    Thromb Res; 2011 Apr; 127(4):363-9. PubMed ID: 21272922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic role of endothelial microparticles in vasculitis.
    Erdbruegger U; Grossheim M; Hertel B; Wyss K; Kirsch T; Woywodt A; Haller H; Haubitz M
    Rheumatology (Oxford); 2008 Dec; 47(12):1820-5. PubMed ID: 18927191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microparticles and arterial disease.
    Blann A; Shantsila E; Shantsila A
    Semin Thromb Hemost; 2009 Jul; 35(5):488-96. PubMed ID: 19739039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microparticles: key protagonists in cardiovascular disorders.
    Amabile N; Rautou PE; Tedgui A; Boulanger CM
    Semin Thromb Hemost; 2010 Nov; 36(8):907-16. PubMed ID: 21069633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
    Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
    Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-derived microparticles: a new challenge in neuroscience.
    Doeuvre L; Plawinski L; Toti F; Anglés-Cano E
    J Neurochem; 2009 Jul; 110(2):457-68. PubMed ID: 19457085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue factor-bearing microparticles and cancer.
    Zwicker JI
    Semin Thromb Hemost; 2008 Mar; 34(2):195-8. PubMed ID: 18645925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-analytical and analytical issues in the analysis of blood microparticles.
    Yuana Y; Bertina RM; Osanto S
    Thromb Haemost; 2011 Mar; 105(3):396-408. PubMed ID: 21174005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procoagulant microparticles: disrupting the vascular homeostasis equation?
    Morel O; Toti F; Hugel B; Bakouboula B; Camoin-Jau L; Dignat-George F; Freyssinet JM
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2594-604. PubMed ID: 16990554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microparticle size and its relation to composition, functional activity, and clinical significance.
    Jy W; Horstman LL; Ahn YS
    Semin Thromb Hemost; 2010 Nov; 36(8):876-80. PubMed ID: 21049388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of tissue factor in hemostasis and thrombosis.
    Mackman N
    Blood Cells Mol Dis; 2006; 36(2):104-7. PubMed ID: 16466951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.